Arteris, INC Form 4 insider transactions

Nicholas B. Hawkins, VP and Chief Financial Officer of Arteris, Inc., sold 10,631 shares of common stock on August 12, 2026.

Bayview Legacy, LLC reported changes in beneficial ownership of Arteris, Inc. common stock on August 3, 2026.

Saiyed Atiq Raza, a Director of Arteris, Inc., sold 70,000 shares of common stock on August 3, 2026.

Paul L Alpern, VP and General Counsel of Arteris, Inc., sold 4,000 shares of common stock on August 3, 2026.

K Charles Janac, President and CEO, a Director and 10% owner of Arteris, Inc., sold 100,000 shares of common stock on August 3, 2026.

Arteris, Inc. reports significant stock sales by President and CEO K. Charles Janac, executed under a pre-arranged 10b5-1 trading plan.

Bayview Legacy, LLC, managed by K. Charles Janac, reported the sale of Arteris, Inc. common stock totaling over 160,000 shares through a pre-arranged 10b5-1 trading plan.

Arteris, Inc. VP and General Counsel Paul L. Alpern sold a total of 6,000 shares of common stock under a pre-arranged 10b5-1 trading plan.

Arteris, Inc. Director Joachim Kunkel received 365 shares of common stock as retainer fees, elected in lieu of cash.

Arteris, Inc. Director Claudia F. Munce acquired 350 shares of common stock as fully vested restricted stock, representing retainer fees elected in lieu of cash.

K. Charles Janac, President and CEO of Arteris, Inc., reported the sale of common stock valued at approximately $3.7 million under a pre-arranged trading plan.

Bayview Legacy, LLC, an entity associated with Arteris, Inc. director K. Charles Janac, has reported the sale of common stock valued at approximately $2.8 million under a pre-arranged trading plan.

Arteris, Inc. Chief Operating Officer Laurent R. Moll sold shares to cover tax liabilities related to restricted stock units, as disclosed in a Form 4 filing.

Arteris Inc. VP and General Counsel Paul L. Alpern reported the sale of 3,656 shares of common stock on July 2, 2026, to cover tax liabilities arising from restricted stock unit releases.

Arteris Inc. VP and CFO Nicholas B. Hawkins sold a total of 5,377 shares of common stock on July 2, 2026, to cover tax liabilities related to the release of restricted stock units.

Arteris, Inc. VP and General Counsel Paul L. Alpern reported transactions involving the sale of common stock and the acquisition of stock options on July 1, 2026, under a pre-arranged 10b5-1 trading plan.

Arteris, Inc. Director Saiyed Atiq Raza has reported the sale of common stock totaling over 70,000 shares through a pre-arranged 10b5-1 trading plan.

Arteris, Inc. Chief Operating Officer Laurent Moll sold 39,541 shares of common stock at $43.15 per share.

Arteris, Inc. President and CEO Charles Janac sold 70,000 shares of common stock via a pre-arranged 10b5-1 trading plan.

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., sold 70,000 shares of common stock via a pre-arranged 10b5-1 trading plan.

Arteris, Inc. Director Antonio J. Viana transferred shares to a family trust and sold 20,839 shares via a 10b5-1 trading plan.

Director Joachim Kunkel was granted 4,703 restricted stock units as part of his compensation for service to Arteris, Inc.

Director Antonio J. Viana was granted 4,703 restricted stock units as part of his compensation for service on the Arteris, Inc. Board.

Director Claudia Munce was granted 4,703 restricted stock units as part of her compensation for service on the Arteris, Inc. board.

Director Raman Chitkara was granted 4,703 restricted stock units as part of his compensation for service to Arteris, Inc.

Director Wayne Cantwell acquired 7,839 restricted stock units in Arteris, Inc. as part of an equity compensation grant.

Director S. Atiq Raza reported a grant of restricted stock units and the subsequent sale of shares held in a family trust.

Arteris, Inc. VP and General Counsel Paul Alpern exercised stock options and sold shares under a pre-arranged 10b5-1 trading plan.

Director Saiyed Atiq Raza of Arteris, Inc. has reported the sale of common stock valued at approximately $2.39 million through a pre-arranged trading plan.

Arteris, Inc. CFO Nicholas Hawkins sold 3,000 shares of common stock at an average price of $37.75 per share.